A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

November 22, 2010

Primary Completion Date

March 8, 2013

Study Completion Date

February 2, 2018

Conditions
Multiple Myeloma
Interventions
DRUG

Ixazomib

Ixazomib capsules

DRUG

Lenalidomide

Lenalidomide capsules

DRUG

Dexamethasone

Dexamethasone tablets

Trial Locations (16)

10021

New York Presbyterian Hospital - Weill-Cornell, New York

21215

Harry and Jeannette Weinberg Cancer Center at Franklin Square Hospital, Baltimore

26506

W VA University Mary Babb Randolph Cancer Center, Morgantown

30322

Emory University, Atlanta

32224

Mayo Clinic Jacksonville, Jacksonville

33140

Mt Sinai Medical Center, Miami Beach

37203

Sarah Cannon Cancer Center, Nashville

48201

Karmanos Cancer Institute, Detroit

53226

The Medical College of Wisconsin, Inc., Milwaukee

55905

Mayo Clinic, Rochester

63110

Washington University, St Louis

80218

Rocky Mountain Cancer Center Rose, Denver

85259

Mayo Clinic Arizona, Scottsdale

90048

Cedars Sinai Medical Center, Los Angeles

06489

Cancer Center of Central Connecticut, Southington

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY